Vural, S. Et Al. 2023. Adalimumab (Humira®) Induced Recurrent Peritonsillar Abscess in A Patient Received Three Different Anti-TNF Therapies: A Case Report. Indian Journal of Otolaryngology and Head and Neck Surgery , vol.75, no.2 , 1013-1015.

Vural, S., Kuşdoğan, M., Kaya, H. B., İkiz, V., & Albayrak, L., (2023). Adalimumab (Humira®) Induced Recurrent Peritonsillar Abscess in A Patient Received Three Different Anti-TNF Therapies: A Case Report. Indian Journal of Otolaryngology and Head and Neck Surgery , vol.75, no.2, 1013-1015.

Vural, SEVİLAY Et Al. "Adalimumab (Humira®) Induced Recurrent Peritonsillar Abscess in A Patient Received Three Different Anti-TNF Therapies: A Case Report," Indian Journal of Otolaryngology and Head and Neck Surgery , vol.75, no.2, 1013-1015, 2023

Vural, SEVİLAY Et Al. "Adalimumab (Humira®) Induced Recurrent Peritonsillar Abscess in A Patient Received Three Different Anti-TNF Therapies: A Case Report." Indian Journal of Otolaryngology and Head and Neck Surgery , vol.75, no.2, pp.1013-1015, 2023

Vural, S. Et Al. (2023) . "Adalimumab (Humira®) Induced Recurrent Peritonsillar Abscess in A Patient Received Three Different Anti-TNF Therapies: A Case Report." Indian Journal of Otolaryngology and Head and Neck Surgery , vol.75, no.2, pp.1013-1015.

@article{article, author={SEVİLAY VURAL Et Al. }, title={Adalimumab (Humira®) Induced Recurrent Peritonsillar Abscess in A Patient Received Three Different Anti-TNF Therapies: A Case Report}, journal={Indian Journal of Otolaryngology and Head and Neck Surgery}, year=2023, pages={1013-1015} }